F. Vena, B. Roubinet and L. Landemarre. (2022) Lectin array for quality control of recombinant biotherapeutic glycoproteins. SynBIOcarb and COST Glyconanoprobes joint conference, March 29 – April 1, 2020; Czech Academy of Sciences, Prague, Czech Republic.
Book in your calendar!!! GLYcoDiag will be present in the next In Cosmetics global 2022 in Paris porte de Versailles from Tuesday 5th to Thursday 7th April 2022 (Stand P105). GLYcoDiag will present the full services intended to microbiote studies and its technology platform GLYcoPROFILE®, intended to the research of new active products and the study of « glyco-actives » mechanisms relevant for cosmetic applications, which allow to reduce your time development and increase your innovation capability. Contact us to book a B2B meeting with us.
Download the GLYcoDiag’s Newsletter February 2022 about cells GLYcoPROFILE studies.
Download the GLYcoDiag’s Newsletter January 2022 about corneocytes interactions studies.
Download the GLYcoDiag’s Newsletter October 2021 about Sambucus nigra agglutinin (SNA) and it added value products.
The Glycosciences products catalogue 2021 are now available to download.
Divoly, A., Zarza, S. M., Landemarre, L., Roubinet, B., Decloquement, P., Raoult, D., Fournier, P.-E., Desnues, B. Human galectin-1 and galectin-3 promote Tropheryma Whipplei infection, Gut microbes, 2021, 13, e1884515 (DOI : 10.1080/19490976.2021.1884515).
GLYcoPROFILE was recently used for the characterization of Tropheryma whipplei, an actinobacterium which causes various infections in humans, including Whipple’s disease. Thus, the GLYcoPROFILE has enabled to characterize the glycan signature of T. Whipplei glycoproteins.
Download the GLYcoDiag’s Newsletter January 2021 about α2.3/α2.6 Neoglycoproteins.